{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:09:03Z","timestamp":1793938143881,"version":"4.8.0"},"reference-count":88,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2026,8,11]]},"DOI":"10.1136\/bmj-2026-100618","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:00:16Z","timestamp":1790679616000},"page":"e100618","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Recommendations for evaluating a single surrogate endpoint (REASSurE): consensus based, surrogate evaluation framework with explanation and elaboration"],"prefix":"10.1136","volume":"394","author":[{"given":"Wang Pok","family":"Lo","sequence":"first","affiliation":[{"name":"Centre for Population Health Sciences, Usher Institute, School of Population Health Sciences, University of Edinburgh, Edinburgh, UK"},{"name":"School of Medicine and Biomedical Sciences, Green Templeton College, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart G","family":"Baker","sequence":"additional","affiliation":[{"name":"Independent researcher, Columbia, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bertolaccini","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"},{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Bujkiewicz","sequence":"additional","affiliation":[{"name":"Biostatistics Research Group, Division of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[{"name":"International Centre for Eye Health (ICEH), London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Buyse","sequence":"additional","affiliation":[{"name":"International Drug Development Institute, Louvain-La-Neuve, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Ciani","sequence":"additional","affiliation":[{"name":"Centre for Research on Health and Social Care Management, SDA Bocconi, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[{"name":"Section for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark"},{"name":"Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Daniels","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, IRCCS European Institute of Oncology, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer A","family":"Gheita","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jaeger","sequence":"additional","affiliation":[{"name":"Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Kareithi","sequence":"additional","affiliation":[{"name":"Biostatistics Research Group, Newcastle University, Newcastle, UK"},{"name":"Jasiri Cancer Research Foundation, Embu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Lassere","sequence":"additional","affiliation":[{"name":"St George Hospital and School of Population Health, University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T","family":"Longford","sequence":"additional","affiliation":[{"name":"SNTL Statistics Research and Consulting, London, UK"},{"name":"Institute of Econometrics, Warsaw School of Economics (SGH), Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M","family":"Manyara","sequence":"additional","affiliation":[{"name":"Global Health and Ageing Research Unit, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Oba","sequence":"additional","affiliation":[{"name":"Interfaculty Initiative in Information Studies, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Iowa, Iowa City, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod S","family":"Taylor","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics & Primary Care and General Practice, School of Health and Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J","family":"Toro-Huamanchumo","sequence":"additional","affiliation":[{"name":"Research Unit for Generation and Synthesis Evidence in Health, Saint Ignatius of Loyola University, Lima, Peru"},{"name":"OBEMET Center for Obesity and Metabolic Health, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steff","family":"Lewis","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, School of Population Health Sciences, University of Edinburgh, Edinburgh EH16 4UX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ensor","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, School of Population Health Sciences, University of Edinburgh, Edinburgh EH16 4UX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6494-4903","authenticated-orcid":true,"given":"Christopher J","family":"Weir","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, School of Population Health Sciences, University of Edinburgh, Edinburgh EH16 4UX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2026092907551101000_394.sep29_2.e100618.1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02333016"},{"key":"2026092907551101000_394.sep29_2.e100618.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.06.013"},{"key":"2026092907551101000_394.sep29_2.e100618.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102283"},{"key":"2026092907551101000_394.sep29_2.e100618.4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00011"},{"key":"2026092907551101000_394.sep29_2.e100618.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.111242"},{"key":"2026092907551101000_394.sep29_2.e100618.6","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780080404"},{"key":"2026092907551101000_394.sep29_2.e100618.7","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.1.2.189"},{"key":"2026092907551101000_394.sep29_2.e100618.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078525"},{"key":"2026092907551101000_394.sep29_2.e100618.9","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780080407"},{"key":"2026092907551101000_394.sep29_2.e100618.10","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780110204"},{"key":"2026092907551101000_394.sep29_2.e100618.11","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6820"},{"key":"2026092907551101000_394.sep29_2.e100618.12","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/1.1.49"},{"key":"2026092907551101000_394.sep29_2.e100618.13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M"},{"key":"2026092907551101000_394.sep29_2.e100618.14","doi-asserted-by":"publisher","DOI":"10.1002\/pst.207"},{"key":"2026092907551101000_394.sep29_2.e100618.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-0420.2008.01014.x"},{"key":"2026092907551101000_394.sep29_2.e100618.16","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12245"},{"key":"2026092907551101000_394.sep29_2.e100618.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111508"},{"key":"2026092907551101000_394.sep29_2.e100618.18","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac006"},{"key":"2026092907551101000_394.sep29_2.e100618.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.10.011"},{"key":"2026092907551101000_394.sep29_2.e100618.20","unstructured":"Institute for Quality and Efficiency in Health Care. Validity of surrogate endpoints in oncology: Executive summary of rapid report a10-05, version 1.1 [internet], 2011. Institute for Quality and Efficiency in Health Care (IQWiG). Cologne, Germany. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK198799. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-27"},{"key":"2026092907551101000_394.sep29_2.e100618.22","unstructured":"Parast L Gilbert P Wu L . Statistical Challenges in the Identification, Validation, and Use of Surrogate Markers. Banff International Research Station for Mathematical Innovation and Discovery. 2022."},{"key":"2026092907551101000_394.sep29_2.e100618.23","first-page":"607","article-title":"Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema","volume":"34","author":"Lassere","year":"2007","journal-title":"J Rheumatol"},{"key":"2026092907551101000_394.sep29_2.e100618.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108722"},{"key":"2026092907551101000_394.sep29_2.e100618.25","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4524"},{"key":"2026092907551101000_394.sep29_2.e100618.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.12.002"},{"key":"2026092907551101000_394.sep29_2.e100618.27","unstructured":"FDA. Context of use, 2021. Available from: https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/context-use. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.28","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource 2016-. Silver Spring (MD): Food and Drug Administration (US). Co-published by National Institutes of Health (US), Bethesda (MD). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.29","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113989"},{"key":"2026092907551101000_394.sep29_2.e100618.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00569-X"},{"key":"2026092907551101000_394.sep29_2.e100618.31","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231198925"},{"key":"2026092907551101000_394.sep29_2.e100618.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02302-4"},{"key":"2026092907551101000_394.sep29_2.e100618.33","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.06.009"},{"key":"2026092907551101000_394.sep29_2.e100618.34","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08600718"},{"key":"2026092907551101000_394.sep29_2.e100618.35","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.03.007"},{"key":"2026092907551101000_394.sep29_2.e100618.36","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16337"},{"key":"2026092907551101000_394.sep29_2.e100618.37","unstructured":"Department of Health and Social Care. The UK Rare Diseases Framework, 2021. Available from: https:\/\/www.gov.uk\/government\/publications\/uk-rare-diseases-framework\/the-uk-rare-diseases-framework. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.38","unstructured":"FDA. Rare diseases at FDA, 2022. Available from: https:\/\/www.fda.gov\/patients\/rare-diseases-fda. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.39","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000666"},{"key":"2026092907551101000_394.sep29_2.e100618.40","unstructured":"FDA. Case Study: Tofersen (Qalsody), 2025. Available from: https:\/\/www.fda.gov\/about-fda\/accelerating-rare-disease-cures-arc-program\/learning-and-education-advance-and-empower-rare-disease-drug-developers-leader-3d#case-studies. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.41","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2024.2447919"},{"key":"2026092907551101000_394.sep29_2.e100618.42","unstructured":"FDA. Application Number 215887Orig1s000 Integrated Review, 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2023\/215887Orig1s000IntegratedR.pdf. 11 December 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.43","unstructured":"ClinicalTrials.gov. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)). NCT02623699. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02623699. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.44","unstructured":"FDA. Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure, 2024. Available from: https:\/\/www.fda.gov\/drugs\/development-resources\/table-surrogate-endpoints-were-basis-drug-approval-or-licensure. 17 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.45","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10137"},{"key":"2026092907551101000_394.sep29_2.e100618.46","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10136"},{"key":"2026092907551101000_394.sep29_2.e100618.47","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30750-2"},{"key":"2026092907551101000_394.sep29_2.e100618.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.06.005"},{"key":"2026092907551101000_394.sep29_2.e100618.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076754"},{"key":"2026092907551101000_394.sep29_2.e100618.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115292"},{"key":"2026092907551101000_394.sep29_2.e100618.51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02279"},{"key":"2026092907551101000_394.sep29_2.e100618.52","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01887-y"},{"key":"2026092907551101000_394.sep29_2.e100618.53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9400"},{"key":"2026092907551101000_394.sep29_2.e100618.54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2026092907551101000_394.sep29_2.e100618.55","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70295-9"},{"key":"2026092907551101000_394.sep29_2.e100618.56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.3.289"},{"key":"2026092907551101000_394.sep29_2.e100618.57","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70063-8"},{"key":"2026092907551101000_394.sep29_2.e100618.58","doi-asserted-by":"publisher","DOI":"10.3389\/frma.2021.675071"},{"key":"2026092907551101000_394.sep29_2.e100618.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2015.05.006"},{"key":"2026092907551101000_394.sep29_2.e100618.60","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6733-x"},{"key":"2026092907551101000_394.sep29_2.e100618.61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.8.790"},{"key":"2026092907551101000_394.sep29_2.e100618.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.02.012"},{"key":"2026092907551101000_394.sep29_2.e100618.63","unstructured":"Swinkels H Nguyen A Gulick P . HIV and AIDS. StatPearls. 2024 Jul 27."},{"key":"2026092907551101000_394.sep29_2.e100618.64","unstructured":"Edwards Z Ingold CJ Azmat CE . Zidovudine. InStatPearls [Internet]. 2023 Jun 5. StatPearls Publishing."},{"key":"2026092907551101000_394.sep29_2.e100618.65","doi-asserted-by":"publisher","DOI":"10.1126\/science.2300816"},{"key":"2026092907551101000_394.sep29_2.e100618.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241201"},{"key":"2026092907551101000_394.sep29_2.e100618.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.02.038"},{"key":"2026092907551101000_394.sep29_2.e100618.68","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00155-8"},{"key":"2026092907551101000_394.sep29_2.e100618.69","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8465"},{"key":"2026092907551101000_394.sep29_2.e100618.70","doi-asserted-by":"crossref","unstructured":"Ren S Singh J Gsteiger S . Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid drugs in Alzheimer\u2019s disease: a Bayesian meta-analysis. arXiv preprint arXiv:2504.06807. 2025.","DOI":"10.57264\/cer-2025-0095"},{"key":"2026092907551101000_394.sep29_2.e100618.71","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X241295665"},{"key":"2026092907551101000_394.sep29_2.e100618.72","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-3-16"},{"key":"2026092907551101000_394.sep29_2.e100618.73","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2015.1094811"},{"key":"2026092907551101000_394.sep29_2.e100618.74","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2219"},{"key":"2026092907551101000_394.sep29_2.e100618.75","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-statistics-032921-035359","article-title":"Surrogate endpoints in clinical trials","volume":"10","author":"Elliott","year":"2023","journal-title":"Annu Rev Stat Appl"},{"key":"2026092907551101000_394.sep29_2.e100618.76","unstructured":"National Institute for Health and Care Excellence. Surrogate endpoints in cost-effectiveness analysis for use in health technology assessment, 2024. Available from: https:\/\/www.nice.org.uk\/what-nice-does\/our-research-work\/our-projects-and-partners\/international-collaboration. 18 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.77","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215597260"},{"key":"2026092907551101000_394.sep29_2.e100618.78","unstructured":"Bujkiewicz S, Achana F, Papanikos T, Riley RD, Abrams KR. NICE DSU Technical Support Document 20: multivariate meta-analysis of summary data for combining treatment effects on correlated outcomes and evaluating surrogate endpoints, 2019. Available from: https:\/\/sheffield.ac.uk\/sites\/default\/files\/2022-02\/TSD20-mvmeta-final.pdf. 18 August 2025."},{"key":"2026092907551101000_394.sep29_2.e100618.79","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X231162852"},{"key":"2026092907551101000_394.sep29_2.e100618.80","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2019-101892"},{"key":"2026092907551101000_394.sep29_2.e100618.81","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2019-105651"},{"key":"2026092907551101000_394.sep29_2.e100618.82","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078524"},{"key":"2026092907551101000_394.sep29_2.e100618.83","doi-asserted-by":"publisher","DOI":"10.1177\/0962280207081865"},{"key":"2026092907551101000_394.sep29_2.e100618.84","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6776"},{"key":"2026092907551101000_394.sep29_2.e100618.85","doi-asserted-by":"publisher","DOI":"10.1111\/biom.13370"},{"key":"2026092907551101000_394.sep29_2.e100618.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2022.107494"},{"key":"2026092907551101000_394.sep29_2.e100618.87","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2024.2429387"},{"key":"2026092907551101000_394.sep29_2.e100618.88","doi-asserted-by":"publisher","DOI":"10.1002\/cesm.70007"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-100618","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-100618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:55:27Z","timestamp":1790693727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-100618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":88,"alternative-id":["10.1136\/bmj-2026-100618"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-100618","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}